The effect of shock on pulmonary alveolar surfactant. Its role in refractory respiratory insufficiency of the critically ill or severely injured patient.
D000818:Animals; D004285:Dogs; D008074:Lipoproteins; D008168:Lung / Q000032:analysis / Q000502:physiology*; D010101:Oxygen Consumption; D010710:Phosphates / Q000097:blood; D010713:Phosphatidylcholines / Q000096:biosynthesis; D010743:Phospholipids / Q000096:biosynthesis; D010759:Phosphorus Isotopes / Q000378:metabolism; D011650:Pulmonary Alveoli / Q000503:physiopathology; D001261:Pulmonary Atelectasis / Q000473:pathology; D012131:Respiratory Insufficiency / Q000503:physiopathology*; D012771:Shock, Hemorrhagic / Q000150:complications*; D013499:Surface Properties; D013500:Surface Tension; D013501:Surface-Active Agents; D013997:Time Factors
D008074:Lipoproteins; D010710:Phosphates; D010713:Phosphatidylcholines; D010743:Phospholipids; D010759:Phosphorus Isotopes; D013501:Surface-Active Agents